Infection Intel

Product Locator

Advanced Technology

Bug of the Month

COVID-19

Environmental Health Care Corner

Environmental Services

HAIs

Hand Hygiene

IC Trends

Long-Term Care Chronicles

Long-Term Care

Operating Room

Mask Respirator

Personal Protective Equipment

Policy

IPC Career

IPLifeline

Pathogen Pulse

Prevention

Sterile Processing Perspectives

Sterile Processing

Surface Disinfection

Vascular Access

News

Media

ICView

Expert Perspectives

Medical World News

Videos

Webinars

Conferences

Conference Coverage

Conference Listing

APIC Chapters

Publication

Infection Control Today

Supplements And Featured Publications

Resources

CME/CE

Editorial Advisory Board

Job Board

Partners

Whitepapers

Subscribe

Educator of the Year

Educator of the Year Official Rules

2024 Educator of the Year Winner

2023 Educator of the Year Winner

The COVID-19 section is a comprehensive resource for clinical news and expert insights on Covid-19. Read more at Infection Control Today.

COVID-19 | Clinical News & Insights | Infection Control Today

Advertise

About Us

Editorial Board

Contact Us

Terms and Conditions

Privacy

Do Not Sell My Personal Information

Facebook

LinkedIn

Spotlight

Featured Articles

Featured Columns

Pathogen Playbook

Topic

View More

1rem

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

 COVID-19 page brings readers the latest information and clinical updates on the coronavirus disease 2019 pandemic, from case counts and hospitalization rates to data on effective treatments for severe disease and the circulating viral variants.  

As infection prevention infrastructure unravels, professionals face déjà vu from the pandemic’s darkest days—making resilience not just important, but essential for survival and progress.

IP LifeLine: Resilience as an Ongoing Journey, Not a Destination

Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC. 

I Was There: An Infection Preventionist on the COVID-19 Pandemic

With staffing shortages and rising infection risks, the TEPHI 200-Series delivers accessible, high-impact training to empower healthcare professionals and strengthen infection prevention efforts nationwide.

Building a Safer Future: How the TEPHI 200-Series IPC Training Is Bridging Critical Gaps in Education

What truly occurred during the COVID-19 pandemic? Is the new COVID.gov website accurate for those who worked in public health throughout the pandemic? A public health worker answers. 

I Was There: A Public Health Worker’s Response to the COVID.gov Rewrite

This week’s Infection Control Today’s Hot Topics in IPC discusses the latest in the measles outbreak, H5N1 in cattle herds, and more.


ICT Hot Topics for April 17, 2025: WHO Member States, Measles, H5N1, and More

Using Genomic Epidemiology to Track Respiratory Virus Transmission in Hospitals

Vatsala Rangachar Srinivasa, MPH, a PhD candidate in epidemiology at the University of Pittsburgh, is focusing her research on genomic epidemiology of respiratory viruses—work she will present at the Society for Healthcare Epidemiology of America (SHEA) Spring Conference from April 27 to 30, 2025, in ChampionsGate, Florida.

As part of the Microbial Genomic Epidemiology Laboratory under Lee Harrison, MD, she contributes to the National Institutes of Health-funded Enhanced Detection System for Health care-Associated Transmission (EDS-HAT). While the team initially focused on bacterial infections, Srinivasa has expanded the scope to include seasonal respiratory viruses, exploring the potential of genomic surveillance in identifying health care-associated transmissions.

“As part of this project, we have established a successful genomic surveillance program to track the spread of bacteria in our hospital, and we are currently working on expanding this to common seasonal respiratory viruses,” Srinivasa told 

. “And we began this work just before the COVID-19 pandemic hit in December 2019. Currently, sequencing respiratory viruses is not standard practice in hospitals for monitoring spread, so we started this project to explore the utility and benefits of routine genomic surveillance of respiratory viruses.”

Her study involved sequencing 4 common respiratory viruses—rhinovirus, influenza, RSV, and human metapneumovirus—across 3 hospitals, 2 serving adults and 1 pediatric. The retrospective analysis included data from 2017 to 2019 and focused on patients who tested positive for these viruses after at least 3 days in the hospital to distinguish likely hospital-acquired infections. Out of approximately 300 sequenced specimens, around 10% were closely genetically related, and 53% of these cases had identifiable hospital-based epidemiological links, such as shared units, overlapping stays, or common health care providers. The remaining 47% lacked identifiable links, suggesting potential transmission from undetected sources such as visitors, health care staff, or the broader community.

While the findings demonstrated clear clusters and transmission patterns, the study's retrospective nature presented limitations. Since the sequencing occurred years after the infections, there was no opportunity to investigate staff illness or real-time interactions that might have explained specific transmission chains. The data collection also preceded the COVID-19 pandemic, when masking and infection control protocols were less stringent, potentially allowing more unmonitored spread.

“Our study focused only on sequencing HAIs, that is, when a person tested positive for respiratory virus on or after 3 days of staying at a hospital. We might not have captured the full scope of transmission. For instance, we did not track or sequence cases, if a patient tested positive on their first or the second day of hospital, [for example], and we also had a few cases where samples from different hospitals were clustering together, or they were closely genetically related, which I found was very interesting, but there was no way for us to see if there was any epidemiological links between them. We have also not explored how infections acquired in the community would play a role in the transmission of these viruses. So what we have found could be an underestimation of transmission.”

Unexpectedly, some genetically linked viruses were found across different hospitals, which presented further questions about the transmission sources and raised the possibility of wider regional or community-based spread. However, the study only looked at infections diagnosed 3 days into a hospital stay or later, potentially underestimating the full scope of transmission, as patients infected earlier were omitted.

Srinivasa emphasized that whole genome sequencing for viral surveillance is not standard in most hospitals, particularly outside large or research-focused institutions. Infection prevention teams often lack access to this level of genomic data, meaning many potential transmission events go unnoticed. Her presentation aimed to showcase how routine genomic surveillance could fill this gap, improving early detection and helping refine infection prevention strategies.

One of the major barriers is that viral sequencing is more complex and costly than bacterial sequencing. Respiratory virus samples are not pure cultures but mixtures of various organisms, requiring additional lab steps to isolate and enrich the virus of interest. These methods are time-consuming and labor-intensive, often taking days to complete. Despite these challenges, Srinivasa’s team has refined its protocols and successfully implemented them in a laboratory setting.

“Implementing this technology presents numerous challenges, especially with viral sequencing, which is more complex than bacterial sequencing,” Srinivasa said. “It tends to be more expensive, labor-intensive, and takes significantly longer to generate results than bacterial sequencing. When we initiated this project in 2019, we spent a lot of time in the lab, optimizing all protocols and refining the genomic analysis methods to ensure effectiveness and achieve project goals." 

Currently, "as we are in the final stages of drafting our manuscript, we anticipate submitting it to a journal for peer review very soon, and we look forward to sharing the results with everyone [soon]. Our next step is to validate these findings further and see the best ways to utilize genomic surveillance for respiratory viruses in hospitals.”

Vatsala Srinivasa, MPH's, research uses genomic sequencing to track hospital transmission of respiratory viruses, revealing hidden links and highlighting the potential for improved infection prevention. 

Conference

The Future of Reusable PPE in Healthcare: A Sustainable and Cost-Effective Solution

The conversation around reusable personal protective equipment (PPE) is gaining traction, especially in the wake of the pandemic-induced shortages. 

 (TRSA), and Dyan Troxel, MSN, RN, the director of clinical education at Handcraft Linen Services, shed light on the benefits and challenges of shifting toward reusable health care textiles. The experts cover key findings from the National Academies of Sciences, Engineering, and Medicine workshop on reusable personal protective equipment (PPE), addressing misconceptions about reusable linens, and current state policy issues.


The National Academies of Sciences, Engineering, and Medicine hosted a workshop to examine the viability of reusable PPE. Findings revealed that reusable textiles offer significant advantages: lower costs, reduced environmental waste, and strengthened supply chain resilience. Unlike disposable PPE, which creates 15,000 tons of waste daily, reusable PPE can withstand up to 75 washes while maintaining its protective integrity.

“The reusable product, specifically reusable PPE in [a] health care environment, it reduced cost, it reduced waste, it improved supply chain resilience, and is a more environmentally sustainable product for the industry. Their ultimate outcome is to explore partnerships with organizations that can help increase the adoption of reusable healthcare PPE,” Ricci said.

Hospitals often hesitate to adopt reusable PPE due to concerns over cleanliness and storage logistics. However, commercial laundries follow rigorous hygienic standards, ensuring that reused PPE meets or exceeds safety requirements. TRSA’s Hygienically Clean Certification ensures that laundering processes eliminate bacteria and contaminants effectively, reinforcing confidence in reusable options.

Troxel said, “We have to convince the people [that the process is safe], and that's part of my job as the clinical educator. I go in and explain the process, invite them to our plant and tour, showcase that we are hygienically clean certified by TRSA, and explain that part of it to get them to understand.”


Despite the benefits, barriers to widespread implementation remain. Many healthcare facilities rely on disposable PPE due to habit, convenience, and purchasing structures tied to group purchasing organizations (GPOs). Decision-makers often view PPE as a disposable commodity rather than a service-based system, making the transition challenging.

Nurses and frontline workers must also feel comfortable using reusable PPE. Studies indicate that 60% of health care workers prefer cloth-based PPE over disposable alternatives due to comfort, durability, and perceived safety. Educating staff and administrators about the efficacy of reusable textiles is essential to shifting mindsets.


Ricci explained that several states, including New York and California, are considering mandates to require at least 50% reusable PPE usage in health care facilities. Europe’s health care sector has already embraced reusable textiles, experiencing fewer PPE shortages during the pandemic. The CDC and other federal agencies could play a pivotal role by recommending reusable PPE in health care guidelines.

“Europe had about 30% more reusable products than Canada, and they avoided shortages because they could rely on that rotating inventory. Since that inventory was available, production continued, allowing them to obtain that product and not [have the shortages we experienced.] They also consider the environment seriously. They are ahead of us on environmental issues, no doubt about it. Just look at their approach to the carbon tax and their efforts on extended producer responsibility and reducing single-use products. It makes a lot more sense to them than it does to us, but we're making progress. I think we're beginning to look at it more universally.”


The shift toward reusable PPE requires a cultural change, strategic investment, and industry-wide collaboration. As health care facilities prioritize sustainability and supply chain resilience, reusable PPE offers a proven, long-term solution.

Ricci said educating health care workers on the benefits of reusable linens is vital. “We're making an effort to sit down with the stakeholders in our industry, collaborate with them, communicate with them, educate them on the importance of the reusable product and what it does within our current healthcare environment and our changing health care environment.”

Troxel agreed and said, “It's about making sure that frontline staff have what they need for their best protection possible to keep patients safe.”

 Annual Conference from May 13 to 15 in Greater Palm Springs. Find information 

Here is a link to the National Academies’ proceedings: 

https://www.nationalacademies.org/our-work/reusable-health-care-textiles-for-personal-protective-equipment-a-workshop

The NAS final report can be found here: 

https://nap.nationalacademies.org/catalog/27762/reusable-health-care-textiles-for-use-in-personal-protective-equipment

Here is a link to the TRSA release, which includes a handy summary of the NAS findings: 

https://www.trsa.org/news/national-academies-workshop-validates-the-benefits-of-reusable-ppe/

Here is a link to the congressional letter requesting the NAS study: 

https://www.trsa.org/wp-content/uploads/2024/06/Letter-to-HHS-Secretary-Becerra-Requst-Study-on-Reusable-Health-Care-Textiles.pdf

Here is some information on the site tour Ricci mentioned with the New York state assemblyperson: 

https://www.trsa.org/news/ny-state-assembly-member-engages-with-trsa-members-tours-unitex/

Here is a link to the New York state bill Ricci mentioned: 

https://www.nysenate.gov/legislation/bills/2023/S8169

Reusable PPE offers a cost-effective, sustainable solution for health care, reducing waste and improving supply chain resilience. Overcoming adoption barriers requires education, policy support, and industry-wide collaboration.

The Future of Reusable PPE in Health Care: A Sustainable and Cost-Effective Solution

Infection Control in Dentistry

Marie Fluent, DDS, dental infection control consultant and speaker at MarieFluent.com, spoke with 

) after her first presentation at the Chicago Dental Society Midwinter Meeting held in Chicago from February 19 to 22, 2025. Her topic was titled “Infection Control Update.”

Fluent, whose dental career spans 35 years, spoke in depth on everything from hand hygiene to waterlines. She is passionate about infection control, especially in dental.

“I love the topic of infection control. It's great public health service. And unlike other topics in dentistry, it's not sexy. In other words, if you adopt a new infection control program, nobody cares. If you got a new CEREC machine, everybody would sit around who and marvel at the technology and the time savings and the chair time savings that would be incorporated in adopting that new piece of technology. But if you have a new infection control program, nobody cares, but I consider it kind of like cleaning your house. If you do clean your house, nobody cares. But if you don't clean your house, everybody notices, and everybody cares. Infection control is in that same category, and it's like a public health service and endeavor that you do out at the bottom of your heart for the goodness of the community, your patients, and the safety and protection of your dental team.”

In the often funny and always engaging presentation, Fluent emphasized vaccinations and how to discuss them with patients and health care workers. “All clinical personnel in the dental setting are at risk for exposure to disease agents and other environmental hazards,” Fluent said. “With attention to infection control CDC guidelines, risks to yourself, your patients, and other dental team members can be minimized…No [vaccines] are perfect. Think of them as “bulletproof” vests. They will not protect 100% of the time, but they do help a great deal.”

At the 2025 Chicago Dental Society Midwinter Meeting, Dr. Marie Fluent passionately discussed infection control, emphasizing hand hygiene, waterlines, and the critical role of vaccinations in dental settings.

Infection Control in Dentistry: Marie Fluent, DDS, Champions Safety and Public Health at Midwinter Meeting

Dr. Deborah Birx Unveils Urgent Insights on Avian Flu: What Infection Preventionists Must Know

Deborah Birx, MD, Unveils Urgent Insights on Avian Flu, COVID-19, and HMPV

This interview can also be found on the podcast

Update: On January 13, 2025, the Animal and Plant Health Inspection Service (APHIS), part of the United States Department of Agriculture (USDA), announced that it has identified highly pathogenic avian influenza (HPAI) in a backyard poultry flock in Puerto Rico. This marks the first occurrence of HPAI in domestic birds in Puerto Rico since the outbreak began in February 2022, 

), Deborah L. Birx, MD, shared critical updates on the evolving threat of avian influenza, particularly the highly pathogenic H5N1 strain. With significant outbreaks reported globally, H5N1 has demonstrated its ability to infect various species, including mammals, raising concerns about its potential to mutate and pose a greater risk to humans.

Birx emphasized the importance of proactive infection prevention strategies to address this growing threat. Key measures include enhanced surveillance systems to monitor both human and animal cases, rigorous biosecurity protocols in agricultural and healthcare settings, and robust public health education campaigns to improve awareness and preparedness.

One of the most alarming aspects of H5N1 is its ability to cross species barriers, potentially increasing the likelihood of mutations that could lead to sustained human-to-human transmission. Birx warned that while current human cases remain isolated, the virus’s evolutionary trajectory necessitates vigilance from infection prevention professionals.

“The reason I [have gotten] concerned over the last month was in California, there are 700 of the 1000 dairy herds infected with H5; 70% of the herds are infected. Less than 60 have moved through their infection and are no longer quarantined. So, we know at least 62 or so percent of all dairy herds are infected in California. And if you look at the h1 from California, well, from the region nine, but it's, you know, heavily California, you'll see that flu h1 is like this. So, h1 is dramatically expanding in California. This will be the first time we have had significant h1 infection in the communities. At the same time, you have dairy workers at risk. The principles of prevention are that responding and detecting are critical.”

She also discussed the importance of personal protective equipment (PPE) adherence for high-risk environments, emphasizing that health care workers and agricultural personnel must be adequately trained to recognize symptoms and prevent exposure. Vaccination strategies for poultry and seasonal flu vaccines for at-risk workers are also essential to minimize co-infection risks.

Birx urged infection preventionists to remain informed about ongoing research, international updates, and potential changes in H5N1 behavior. She stressed that early detection and swift action are critical to preventing more significant outbreaks and protecting public health. Her call to action underscores infection prevention professionals' vital role in mitigating the risks of avian flu and other emerging infectious diseases.

This exclusive interview offers timely and actionable insights, equipping infection preventionists with the knowledge needed to address the evolving challenges of H5N1 and safeguard global health.

"I was hoping we had learned from COVID-19 that a lot of transmission happens between people who don't believe that they have an illness and others," Deborah Birx, MD, told Infection Control Today. 


Ambassador Deborah L. Birx, MD, Unveils Urgent Insights on Avian Flu, COVID-19, and HMPV

Invivyd Presents Data on Pemgarda’s Efficacy Against COVID-19 Variants at IDWeek

Immunocompromised people are the most at risk to severe issues with At IDWeek in Las Angeles, California, 

, a COVID-19 prevention option with FDA Emergency Use Authorization, presented data demonstrating the efficacy of Pemgarda against COVID-19 strains dating back to the Omicron strain for immunocompromised people.

) caught up with Robert Allen, PhD, Invivyd's chief science officer. He explained the main takeaway from his presentation and discussed the 2 posters Invivyd presented at IDWeek.

“The main thing to give them data, empirical underpinnings, so that they can understand that this antibody, which is as an [emergency use authorization] for administration to immunocompromised individuals, right that this antibody has profound efficacy, during the course of canopy, has demonstrated efficacy during times when we saw when we look at the variants that were prevalent at the different time points in those 6 months…[many] different variants that have sort of evolved [to] continue to be susceptible to Pemgarda,” Allen said.

“The takeaway needs to be that when people think about recommending this for use in the context of transplant or individuals [who] are being administered compounds that lead to an immunocompromised state in the context of treatment for other diseases that they might be suffering from, those immunocompromised individuals could benefit from this in the eyes of their positions, and that conversation can be fueled by the confidence they have from seeing this data,” Allen said.

When asked what the IDWeek conference is like, Allen said, “I typically spend a lot of time at research meetings, and [I] was really excited for the opportunity to [go] and talk to health care providers and listen to how the epidemiology groups and others are talking about different pathogens, of course, and there's a lot of enthusiasm around the work that's been done in the clinic. Take, for example, respiratory syncytial virus (RSV); there have been [several] approvals for RSV vaccines and an antibody for the treatment of that disease. And then that, you know, things like that, where I can hear the epidemiologists and like the people from CDC talk about how policies are being put in place, and then use that as a context to think about where a company like Invyvid could position value in that context, right? And so that's been really interesting for me.”

At IDWeek, Invivyd highlighted Pemgarda’s effectiveness under FDA Emergency Use Authorization for immunocompromised patients, demonstrating efficacy against evolving COVID-19 variants since the Omicron strain.

Andrea Thomas, PhD, DVM, MSc, BSC, director of epidemiology at BlueDot, discusses the resurgence of respiratory viruses, risks from avian influenza

Preparing for a Challenging Winter: Insights on Global Infectious Disease Trends

In a recent webinar, Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot at BlueDot Global, and her team provided insights into the current landscape of infectious diseases globally, focusing on respiratory pathogens impacting the Northern Hemisphere. To learn more, 

) attended the webinar and then interviewed Thomas about the details.

With seasonal viruses such as influenza and respiratory syncytial virus (RSV) resurging alongside the ever-present COVID-19, health care systems are preparing for what could be another challenging winter.

“This is the time of year where, at least in Northern Hemisphere countries, we anticipate the return of seasonal respiratory viruses like seasonal flu and RSV, among a number of others. And BlueDot does a lot of monitoring around the global circulation of these pathogens. And of course, we also keep a close eye on COVID-19, which is not seasonal, but often does have a significant rise in cases in the winter, when we also have flu and RSV and others.”

The Southern Hemisphere’s recent experiences indicate a return to prepandemic patterns, although COVID-19’s year-round presence continues to pressure health care infrastructure.

“[The webinar was] to help get ahead of the Northern Hemisphere season and to look at what we saw in the Southern Hemisphere, which can be informative to understand what we might expect in the Northern Hemisphere,” Thomas said.

The webinar emphasized the importance of monitoring global disease trends to anticipate and manage regional outbreaks effectively. Additionally, Thomas discussed the potential risks posed by avian influenza H5N1, which is now detected in dairy cattle and poses an increased risk of human spillovers in agriculture workers. Although H5N1 currently poses a low risk to the public, it highlights the ongoing need for comprehensive surveillance and vaccination strategies to mitigate potential cross-species transmission.

Thomas explained, “So we touched on that too, to talk about added challenges when it comes to surveillance, when it comes to monitoring closely to understand whether that [H5N1] virus might be changing or potentially, if we had worst case scenario, some spread from human to human, how hard that would be to pick up when we've also got all of these other respiratory diseases at the same time.”

Thomas then addressed the challenges posed by emerging and reemerging vector-borne diseases such as dengue and chikungunya. These diseases have shown significant spread in regions like Brazil and are now beginning to circulate locally in parts of the US. This increase in cases reinforces the importance of vector control and public health measures to limit local transmission.

Moreover, the discussion touched on the Marburg virus, a highly fatal hemorrhagic fever similar to Ebola. Although primarily endemic to certain parts of Africa, recent outbreaks have emphasized the need for global vigilance. Thomas highlighted the rapid deployment of trial vaccines in response to the latest outbreaks, underscoring the critical role of proactive research and preparedness in managing viral threats.

Infection preventionists and health care facilities can mitigate the impact of respiratory diseases this season by strengthening preventive measures and significantly enhancing ventilation systems to reduce airborne transmission. As Thomas noted, being proactive, rather than reactive, in infection control will be key to minimizing health care-associated infections and protecting health care workers and patients from severe illnesses during the upcoming high-risk winter season.

Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot, discusses the resurgence of respiratory viruses, like COVID-19, influenza, pneumonia, and risks from avian influenza, and the importance of proactive infection control to safeguard health care systems this winter.

 Infection Prevention in Veterinary Medicine: A Growing Field with New Challenges

Bluedot Veterinary infection prevention

 has increasingly become a focal point in the conversation about infection prevention. During an interview with 

), Andrea Thomas, DVM, PhD, MSc, BSc, director of epidemiology at BlueDot Global, and Mariana Torres Portillo, MD, infectious disease surveillance manager at BlueDot Global, highlighted how the recent COVID-19 pandemic underscored the importance of preventing the spread of viruses between humans and animals. The transmission of diseases, such as COVID-19 and mpox, not only among humans but also to pets and wildlife, has opened up a wider discussion about zoonotic diseases that spread between animals and people.

Thomas acknowledged that veterinarians often act as generalists, managing everything from surgery to routine checkups, all while trying to prevent the spread of infections. This tall order is why a more specialized focus on veterinary infection prevention is gaining traction. There is a growing recognition of the need to fill knowledge gaps, particularly with emerging diseases, and to create guidelines to help professionals avoid potential outbreaks.

“The current pandemic that we’re still in has brought that to light,” Thomas told 

. We had a new virus spreading between people, but it could also be passed to our pets. That alone has brought a lot of attention to the need to prevent the sharing of viruses and pathogens between animals and humans….

 That’s a tall order, and it is great to know that this is a growing field and [that there is] a growing…recognition of the need to fill those gaps and have people who are dedicated to thinking about this problem, communicating around it, and developing guidelines, because we don’t always have those—especially with emerging infectious diseases—in veterinary health care.

“It’s a lot to stay on top of. You’re already treating the patients in front of you. [Still], you also need to understand what could be coming your way that you need to prepare for. [It] is a tall order, and having professionals who are dedicated to monitoring those trends, getting ahead of them, and developing guidelines before they’re needed, hopefully, is going to be a huge benefit to the field,” Thomas continued.

For instance, zoonotic diseases account for an estimated 75% of emerging infections.

 Recent research from China has identified dozens of animal viruses that could become future public health threats.

 As Torres Portillo emphasizes, professionals dedicated to monitoring these threats and developing proactive guidelines will be essential for keeping both animals and humans safe.

“I think we should first…[improve] the air quality…. [There are] many discussions into airborne pathogens, droplets vs aerosols, that have been concealed to further prevent [pathogens]. [At the] top [of the list will]be handwashing for many pathogens, [as] that is another way of transmission.” Torres Portillo said.

Regarding recommendations for veterinary infection preventionists, the focus is on fundamental actions, such as air filtration, improved hand hygiene, and a One Health approach that integrates human, animal, and environmental health. Torres Portillo also highlighted the need to protect veterinary professionals, as they are often in direct contact with animals and their fluids, increasing their risk of exposure.

A key opportunity is a more vital collaboration between human and veterinary infection prevention teams. Learning from human health experiences can help enhance veterinary protocols, bridging gaps across both fields.

“Just like in health care, these are critical resources…. We don’t have enough of them in veterinary medicine, either.” Thomas said. “There is a shortage, and we need to protect their health. That’s absolutely critical…and I do think there are gaps. It is an area that hasn’t had as much focus as it has for human health. It’s also asking a lot for public health to take on that responsibility, too, where there may not be as much expertise. Having a dedicated veterinary infection prevention training, [having] guidelines developed, [and] building that field up would be valuable across multiple fronts.”

Both Thomas and Torres Portillo see opportunities for a stronger collaboration between human and veterinary infection prevention teams. “This whole conversation is how we’re all connected. We can’t have a separation between human and animal health, so I think it will have to be very cross-collaborative,” Thomas said.

Whitacre Martonicz T. Veterinary infection prevention: a discussion with Leslie Kollman, BS, CVT, CIC. 

. June 20, 2024. Accessed October 28, 2024. 

https://www.infectioncontroltoday.com/view/veterinary-infection-prevention-discussion-leslie-kollmann-bs-cvt-cic

’s editorial advisory board member: David Levine, PhD, DPT, MPH, FAPTA. 

. August 21, 2024. Accessed October 28, 2024. 

https://www.infectioncontroltoday.com/view/meet-infection-control-today-s-editorial-advisory-board-member-david-levine-phd-dpt-mph-fapta

Milbank C, Vira B. Wildmeat consumption and zoonotic spillover: contextualising disease emergence and policy responses. 

. 2022;6(5):e439-e448. doi:10.1016/S2542-5196(22)00064-X

Zhao, J, et al. Farmed fur animals harbour viruses with zoonotic spillover potential, 

Veterinary medicine's growing focus on infection prevention aims to address zoonotic disease risks, emphasizing specialized training, proactive guidelines, and collaboration between human and veterinary health teams.


 Infection Prevention in Veterinary Medicine: A Growing Field With New Challenges

Meet Shannon Simmons, DHSc, MPH, CIC. Infection Control Today's Editorial Advisory board member

Meet Shannon Simmons, DHSc, MPH, CIC.

's) Editorial Board members—a diverse group of professionals dedicated to advancing infection prevention and control practices. This series highlights each member's unique expertise and contributions to the field.

From groundbreaking research to innovative strategies, these experts are at the forefront of enhancing health care safety. Join us as we learn their insights, experiences, and visions for the future, providing valuable knowledge and inspiration to elevate infection control protocols.

This installment is from Shannon Simmons, DHSc, MPH, CIC, System Program Manager of Ambulatory Infection Prevention for CHRISTUS Health, Irving TX.

Meet the experts shaping infection prevention: Infection Control Today's Editorial Board members share insights, experiences, and cutting-edge strategies to enhance health care safety and quality. Meet Shannon Simmons, DHSc, MPH, CIC.

COVID-19

Latest News